Log In
BCIQ
Print this Print this
 

Acarovac Plus

  Manage Alerts
Collapse Summary General Information
Company Allergy Therapeutics plc
DescriptionTyrosine-adsorbed, modified-allergen product containing extracts of selectively purified allergens from house dust mite
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationAllergy
Indication DetailsTreat allergic rhinitis and/or asthma; Treat perennial mite allergy
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today